Optimal use of quick-acting insulin analogue in combination with basal insulin and its long-term effect in Japanese children and adolescents with type 1 diabetes

被引:3
|
作者
Urakami, T [1 ]
Inami, I [1 ]
Morimoto, S [1 ]
Owada, M [1 ]
Harada, K [1 ]
机构
[1] Nihon Univ, Sch Med, Dept Pediat, Chiyoda Ku, Tokyo 1018309, Japan
关键词
type; 1; diabetes; pediatric patients; quick-acting insulin analogue; adjustment of insulin regimens; glycemic control;
D O I
10.1016/j.diabres.2004.08.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the study was to examine the optimal use of quick-acting insulin analogue (Q) switching from regular insulin (R) in combination with basal insulin and its long-term effects in 40 Japanese children and adolescents with type I diabetes. Insulin regimens after administration of Q were increased to twice daily injections of basal insulin and modified use of Q or R as bolus insulin depending on the blood glucose profile and lifestyles. The mean dose of total insulin remained unchanged during treatment with using Q, but that of basal insulin increased 12 months after the use of Q (baseline: 25.8 +/- 12.2, after 12 months: 27.1 +/- 12.6 U/day). After switching to Q, the mean HbA1c value decreased in all patients (baseline: 7.6 +/- 1.0, after 12 months: 7.3 +/- 0.8%), which reflected improvement of HbA1c in patients with HbA1c 8% at baseline. These results indicated that insulin regimens after switching from R to Q varied with increases of the number and the dosage of basal insulin. Use of Q seems to be useful to improve hyperglycemia in patients with a poor glucose profile under conventional insulin treatment with using R. The choice of insulin regimens with using Q in consideration of the blood glucose profile as well as lifestyles may lead to better glycemic control. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:96 / 103
页数:8
相关论文
共 50 条
  • [41] Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with Type 1 diabetes
    Bott, U
    Ebrahim, S
    Hirschberger, S
    Skovlund, SE
    DIABETIC MEDICINE, 2003, 20 (08) : 626 - 634
  • [42] The long-term treatment of a patient with type 1 diabetes mellitus and glutaric aciduria type 1: the effect of insulin
    Del Rizzo, Monica
    Galderisi, Alfonso
    Celato, Andrea
    Furlan, Francesca
    Giordano, Laura
    Cazzorla, Chiara
    Fasan, Ilaria
    Moretti, Carlo
    Zschocke, Johannes
    Burlina, Alberto B.
    EUROPEAN JOURNAL OF PEDIATRICS, 2016, 175 (08) : 1123 - 1128
  • [43] The long-term treatment of a patient with type 1 diabetes mellitus and glutaric aciduria type 1: the effect of insulin
    Monica Del Rizzo
    Alfonso Galderisi
    Andrea Celato
    Francesca Furlan
    Laura Giordano
    Chiara Cazzorla
    Ilaria Fasan
    Carlo Moretti
    Johannes Zschocke
    Alberto B. Burlina
    European Journal of Pediatrics, 2016, 175 : 1123 - 1128
  • [44] Long-acting insulin analogue detemir compared with NPH insulin in type 1 diabetes A systematic review and meta-analysis
    Szypowska, Agnieszka
    Golicki, Dominik
    Groele, Lidia
    Pankowska, Ewa
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2011, 121 (7-8): : 237 - 246
  • [45] COMPARATIVE COST-UTILITY ANALYSIS OF LONG-ACTING INSULIN ANALOGUE (INSULIN DETEMIR) AND NPH INSULIN FOR THE TREATMENT OF TYPE 1 AND TYPE 2 DIABETES AND THE BUDGET IMPACT ANALYSIS OF INSULIN ANALOGUE REIMBURSEMENT IN POLAND
    Walczak, J.
    Pawlik, D.
    Jasinska, A.
    Garbacka, M.
    Kedzior, J.
    Fundament, T.
    Malczak, I
    Dardzinski, W.
    Skrzekowska-Baran, I
    Czech, M.
    Nogas, G.
    VALUE IN HEALTH, 2008, 11 (06) : A500 - A500
  • [46] Insulin degludec: a novel ultra- long-acting basal insulin for use in Type 1 and 2 diabetes (vol 7, pg 9, 2012)
    Meneghini, L. F.
    Miranda-Palma, B.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2012, 7 (02) : 246 - 246
  • [47] Efficacy and safety of a fixed combination of insulin degludec/insulin aspart in children and adolescents with type 1 diabetes: A randomized trial
    Battelino, Tadej
    Deeb, Larry C.
    Ekelund, Magnus
    Kinduryte, Ona
    Klingensmith, Georgeanna J.
    Kocova, Mirjana
    Kovarenko, Margarita
    Shehadeh, Naim
    PEDIATRIC DIABETES, 2018, 19 (07) : 1263 - 1270
  • [48] Are insulin kinetics reproducible after long-term intraperitoneal insulin treatment in patients with type 1 diabetes
    Lassmann-Vague, V
    Alessis, C
    Vague, P
    Belicar, P
    DIABETOLOGIA, 1998, 41 : A227 - A227
  • [49] Long-term Effect of Biomineralized Insulin Nanoparticles on Type 2 Diabetes Treatment
    Xiao, Yun
    Wang, Xiaoyu
    Wang, Ben
    Liu, Xueyao
    Xu, Xurong
    Tang, Ruikang
    THERANOSTICS, 2017, 7 (17): : 4301 - 4312
  • [50] Efficacy of Rapid-Acting and Long-Acting Insulin Analogs in Japanese Patients with Type 1 Diabetes Mellitus
    Ozaki, Nobuaki
    Nomura, Yoshio
    Wanibe, Harumatsu
    Yamamori, Ikuo
    Oiso, Yutaka
    DIABETES, 2009, 58 : A524 - A524